Purpose: Posterior polymorphous corneal dystrophy (PPCD) is an autosomal-dominant disorder of the corneal endothelium associated with visually significant corneal edema and glaucoma. Statistical genetic analysis of 4 families with PPCD has demonstrated linkage to a 2.4 cM common support interval on chromosome 20 bordered by the markers D20S182 and D20S139. We sought to identify the genetic basis of PPCD linked to chromosome 20 (PPCD1) by screening the 26 positional candidate genes between these markers in a family previously mapped to the PPCD1 region.
Purpose: Posterior polymorphous corneal dystrophy (PPCD) is an autosomal-dominant disorder of the corneal endothelium associated with visually significant corneal edema and glaucoma. Statistical genetic analysis of 4 families with PPCD has demonstrated linkage to a 2.4 cM common support interval on chromosome 20 bordered by the markers D20S182 and D20S139. We sought to identify the genetic basis of PPCD linked to chromosome 20 (PPCD1) by screening the 26 positional candidate genes between these markers in a family previously mapped to the PPCD1 region.
Methods: The coding regions of the 26 positional candidate genes mapped to the common PPCD1 support interval were amplified and sequenced in affected and unaffected individuals from a family previously linked to the PPCD1 locus. Nine other genes positioned just outside of the common PPCD1 support interval but within the autosomal-dominant congenital hereditary endothelial dystrophy interval were also screened.
Results: Four DNA sequence variants in 3 of the positional candidate genes demonstrated complete segregation with the affected phenotype: p.Thr109Thr (rs6111803) in OVOL2, p.Arg56Gln (novel variant-RPSnovel) in RPS19P1, and p.Thr85Thr (rs1053834) and p.Pro99Ser (rs1053839) in C20orf79. Each of these 4 sequence variants demonstrated significant linkage with the affected phenotype in this family (P = 2.5 3 10 -7 for RPSnovel, rs1053834 and rs1053839; P = 8.6 3 10 -7 for rs6111803). However, we also identified each of these 4 sequence variants in $9% unaffected control individuals. The haplotype on which the disease-causing mutation is segregating was found to have a population frequency of 4.2% in the CEPH HapMap trios. Although a number of other previously described and novel single nucleotide polymorphisms were identified in the 35 positional candidate genes located within the PPCD1 and congenital hereditary endothelial dystrophy intervals, none segregated with the affected phenotype.
Conclusions:
We report the absence of a presumed pathogenic coding region mutation in the common PPCD1 support interval. Although minor alleles of 4 single nucleotide polymorphisms were identified that segregated with the affected phenotype, the relatively high frequency of each minor allele in the general population indicates that none is a candidate for the causal variant for PPCD. Instead, the causal variant is most likely a coding region deletion or a variant in a noncoding region of the PPCD1 common support interval.
INTRODUCTION
Posterior polymorphous corneal dystrophy (PPCD, MIM #122000) is an autosomal-dominant corneal endothelial dystrophy associated with a varied affected phenotype ranging from asymptomatic corneal endothelial changes in the majority of patients to congenital corneal edema and glaucoma in the most severely affected individuals. Locus heterogeneity has been demonstrated for PPCD. Pathogenic mutations have been identified in the zinc finger E-box binding homeobox 1 gene (MIM 189909), also known as the transcription factor 8 gene, on chromosome 10 in 17 families with PPCD (PPCD3). [1] [2] [3] Another locus, PPCD1, was demonstrated by linkage to the pericentromeric region of chromosome 20, first by Heon and colleagues 4 and more recently by Gwilliam and colleagues 5 and our group. 6 The region of chromosome 20 that is contained within the support interval for PPCD in all 3 studies, the PPCD1 common support interval ( Fig. 1) , is a 2.4 cM region between markers D20S182 and D20S139 that includes 26 mapped genes (http://www.ncbi.nlm.nih.gov; build 36.3). Based on the assumption that the genetic basis of PPCD is the same in each of the families linked to this region of chromosome 20, we sought to identify the causal variant by screening these 26 positional candidate genes in a large white American PPCD1-linked family that we reported previously. 6 Autosomal-dominant congenital hereditary endothelial dystrophy (CHED1, MIM #121700), characterized by corneal endothelial dysfunction and stromal edema in the first decade of life, has been mapped to a region of chromosome 20 nearly identical to the PPCD1 common support interval ( Fig. 1) . 7 The 35 genes mapped to the 2.7 cM CHED1 support interval between markers D20S48 and D20S471 include the 26 genes within the PPCD1 common support interval as well as 7 genes adjacent to the telomeric border and 2 genes adjacent to the centromeric border. Because the support intervals for CHED1 and PPCD1 are nearly identical, it remains to be determined whether CHED1, which demonstrates significant clinical and histologic similarities to PPCD, 8-10 may actually represent an early-onset variant of PPCD and not a distinct clinical entity. Therefore, we also screened the 9 genes outside the common PPCD1 support interval but within the CHED1 support interval.
MATERIALS AND METHODS
The researchers followed the tenets of the Declaration of Helsinki in the treatment of the subjects reported here. Study approval was obtained from the Institutional Review Board at the University of California, Los Angeles (UCLA Institutional Review Board #02-10-092-01).
Patient Identification/DNA Collection and Preparation
The diagnosis of PPCD was based on the presence of established clinical criteria. 6 DNA collected from affected and unaffected members of a large white family with PPCD1 was isolated as previously described. 6 DNA collected from unaffected, unrelated individuals served as controls.
Selection of DNA Samples for Screening
DNA samples from 2 affected members and 2 unaffected members of the family were selected for screening of the positional candidate genes. A DNA sample from an individual who was not related to any of the members of the family or their spouses was also screened as a control specimen. If a sequence variant was identified in both affected individuals, and in neither of the unaffected family members nor in the unrelated control sample, then the variant was studied in 25 additional pedigree members: 9 affecteds, 9 unaffecteds, and 7 spouses of unknown, although presumed unaffected, status. 
Polymerase Chain Reaction Amplification

DNA Sequencing
Purification of the polymerase chain reaction (PCR) products was achieved by incubating 15 to 30 ng DNA with 5 U Exonuclease I and 0.5 U Shrimp Alkaline Phosphatase (USB Corp., Cleveland, OH) for 15 minutes at 37°C. After inactivation of the nucleases for 15 minutes at 80°C, sequencing reactions were performed by the addition of 2 mL BigDye Terminator Mix v3.1 (Applied Biosystems, Foster City, CA), 2 mL of SeqSaver (Sigma-Aldrich), and 0.2 mL primer (10 pM/mL). Samples were denatured at 96°C for showing the reported candidate gene intervals for PPCD1 and CHED1 and the positions of the markers that define each candidate gene region. The region of chromosome 20 that lies within all 3 regions to which PPCD has been mapped, the common PPCD1 interval, is defined by the markers D20S182 and D20S139. The 4 DNA sequence variants identified within the 2.4 cM common PPCD1 interval that demonstrated complete segregation with the affected phenotype in a family previously linked to the PPCD1 locus are shown.
2 minutes then cycled 25 times at 96°C for 10 seconds, 50°C for 5 seconds, and 60°C for 4 minutes. Unincorporated nucleotides were removed using the CleanSeq reagent and an SPRI plate (Agencourt Bioscience Corporation, Beverly, MA), resuspended in 0.1mM EDTA, and then analyzed on an ABI-3100 Genetic Analyzer (Applied Biosystems). Nucleotide sequences, read manually and with Mutation Surveyor v2.2 (Softgenetics, State College, PA), were compared with the published cDNA sequences for each gene (Table 1) .
Statistical Analysis
For sequence variants that demonstrated segregation with the PPCD phenotype in the pedigree, linkage analysis was performed using the gamete competition option of the statistical genetics software package Mendel 8.0 (www.genetics.ucla. edu/software/mendel). 11 Gamete competition is a generalization of the TDT test for linkage. This statistical analysis can make full use of all the information in extended pedigrees and is much less sensitive to missing data than the standard TDT test. 12 CEPH HapMap data for the single nucleotide polymorphisms (SNPs) rs6111803, rs1053834, and rs1053839 was downloaded from the HapMap web site and analyzed using Haploview. 13, 14 Linkage disequilibrium in the CEPH HapMap trios is reported as r 2 .
RESULTS
Screening of the 26 Positional Candidate Genes in the Common PPCD1 Interval
Sequence variants were identified in 19 of the 26 genes located within the common PPCD1 support interval (Table 1) . Fifty-one variants were identified in total, 32 of which were previously identified SNPs and 19 of which were novel variants. Initial screening identified 3 previously identified SNPs and one novel sequence variant that demonstrated potential segregation with PPCD in the pedigree. For each of these 4 SNPs, the minor frequency allele was present in both affected family members, absent in both unaffected family members, and absent in the unrelated control sample. These 4 SNPs were then screened in additional pedigree members.
The first of these SNPs, c.327C.A (p.Thr109Thr; rs6111803) in OVOL2, was heterozygous in all 11 affected individuals screened and homozygous in the major allele in all 11 unaffected family members and the 7 spouses. The minor allele of this SNP was found in 9% (11 of 118) of control individuals (all heterozygous) and in 20% of the white individuals from the CEPH collection in the International HapMap project (http://www.hapmap.org).
The second and third of these SNPs were identified in the same gene, C20orf79: c.255C.T (p.Thr85Thr; rs1053834) and c.295C.T (p.Pro99Ser; rs1053839). Both of these SNPs were heterozygous in 10 of the 11 affected individuals screened and homozygous in the minor allele in the eleventh. These 2 SNPs were homozygous in the major allele in all 11 unaffected family members and 6 of the 7 spouses; they were both heterozygous in the seventh spouse. The minor alleles of these 2 SNPs, rs1053834 and rs1053839, were found in 31% (31 of 100) of control individuals, slightly higher than their rates in white individuals from the CEPH collection in the International HapMap project, 23% and 24%, respectively.
The novel sequence variant was identified in RPS19P1: c.167G.A (p.Arg56Gln; RPSnovel). This novel SNP followed exactly the same pattern of heterozygosity and homozygosity in the individuals genotyped as the 2 SNPs in C20orf79. The minor allele of this novel SNP was found in 17% (17 of 100) of control individuals.
Screening of 7 Additional Genes Within the CHED1 Interval
Sequence variants were identified in 6 of the 9 genes located within the CHED1 interval but outside of the common PPCD1 interval (Table 1) . Twelve variants were identified in total, 11 of which were previously identified SNPs. The minor allele of each of these sequence variants was present in either one or both of the unaffected family members who were screened. No further screening was performed with these 12 SNPs.
Gamete Competition: Testing for Linkage
We tested for distorted transmission of SNPs rs6111803, rs1053834, rs1053839, and RPSnovel. As expected, the linkage between each SNP and the disease allele was highly statistically significant with a P , 10 -6 for each SNP ( Table 2 ). The results showed that the minor allele was much more likely to be transmitted to affected individuals for each SNP with the ratio of transmission likelihoods greater than 400:1.
Estimation of Haplotype Frequencies
The haplotype on which the disease-causing mutation is segregating was found to have a population frequency of 4.2% in the CEPH HapMap trios (Fig. 2) . The linkage disequilibrium (LD) among the 3 PPCD-associated SNPs genotyped by the HapMap consortium is shown in Figure 3 . The SNPs rs1053834 and rs1053839 are in complete LD (r 2 = 1.0) in the CEPH HapMap trios. There is no LD between rs6111803 and either rs1053834 or rs1053839 (r 2 = 0.022 and 0.028, respectively), which is expected considering that the distance between rs6111803 and the other 2 SNPs is approximately 770 Kbp. The haplotype seen in the family extends much further than is found in the general European population.
DISCUSSION
We believe that the same genetic basis for PPCD1 is shared by the 4 families in which statistical analysis has demonstrated linkage to the pericentromeric region of chromosome 20. Based on this assumption, the pathogenic mutation(s) should lie within one of the 26 genes mapped to the 2.4 cM region that is common to the linked support intervals of each of the 4 families. Sequencing of these 26 positional candidate genes in one of the 4 families revealed 4 sequence variants that segregated with the affected phenotype. However, each variant was also identified in at least 9% of control individuals who were screened. Because PPCD is highly penetrant, none of these 4 coding region variants with relatively high minor allele frequencies is a candidate for the causal variant for PPCD. Instead, it is likely that each of these 4 sequence variants is linked to a much less frequent, pathogenic variant. However, the demonstration of linkage of each of these SNPs with the disease allele provides additional support for our previous conclusion that the pathogenic mutation in the family we report lies within the refined PPCD1 interval. 6 As a result of the very similar linkage support intervals and clinical features shared by CHED1 and PPCD, we believe CHED1 may simply represent a severe, early-onset form of PPCD. Therefore, we also screened the 9 genes located within the CHED1 interval but immediately telomeric or centromeric to the common PPCD1 interval. Again, no presumed pathogenic coding region variants were identified. Thus, we are now able to exclude a coding region mutation in the CHED1 interval, which contains the common support interval for PPCD1. Recently, Heon and colleagues also reported the absence of coding region variants in 3 of the 35 genes mapped to the common PPCD1/CHED1 interval, RBBP9, ZNF133, and SLC24A3, in several members of the original PPCD family linked to the pericentromeric region of chromosome 20. 15 There are several explanations for the absence of coding region mutations in the common support interval for PPCD1: the presence of a mutation in a yet to be described coding region; locus heterogeneity with a different genetic basis for PPCD1 in the family that we report than in one of the families reported by Gwilliam and colleagues 5, 6 ; an error in the assignment of the boundaries for the common support interval; a deletion or a genomic rearrangement involving a PCR primer binding site; or a noncoding region mutation in the common support interval for PPCD1. Although it is possible that PPCD1 is caused by a mutation in a yet to be described gene, 6 years after the publication of the DNA sequence of human chromosome 20, gene annotation is essentially complete. 16 Locus heterogeneity for PPCD on chromosome 20 also seems unlikely because it violates the general scientific rule of parsimony: the simplest explanation is best. Because the support intervals on chromosome 20 overlap in the published PPCD linkage studies, the great weight of the statistical evidence is that a causal variant exists in the common PPCD1 interval.
An error in the assignment of the boundaries of the support interval for PPCD1 reported by Gwilliam and colleagues 5 could explain the absence of a presumed pathogenic mutation in the genes located between the flanking markers D20S48 and D20S139. In fact, such an error in fine mapping the candidate gene interval for another corneal dystrophy, Schnyder corneal dystrophy (MIM #121800), was recently reported. After screening of the coding regions of the genes mapped to the candidate interval failed to identify the genetic basis of Schnyder corneal dystrophy, mutations were identified in the UBIAD1 gene located 368 Kbp outside of the candidate gene interval. [17] [18] [19] [20] Because it remains most likely that the genetic basis for PPCD1 is shared by the 4 families in which linkage to the pericentromeric region of chromosome 20 has been demonstrated, we believe that the most plausible explanations for our not identifying a coding region mutation in the common PPCD1 support interval are a coding region deletion or a noncoding mutation within a promotor or intron that affects transcript expression and/or integrity. An alternative mechanism of overlooking a causative mutation could be the result of the presence of a variant within the PCR primer binding site that would allow only the normal exon to be amplified. Likewise, a deletion that involves a PCR binding site and a portion or all of an exon would not result in an amplified product and therefore would not be detected by targeted sequencing. Instead, only the wild-type allele, present in the hemizygous state, would be amplified. Although the identification of a heterozygous polymorphism in an exon would indicate that both alleles were present, it is possible that PPCD1 is associated with a deletion or genomic rearrangement involving a PCR binding site for one of the .150 exons of the 35 positional candidate genes that we amplified in which no heterozygous SNPs were identified.
Presumed pathogenic intronic variants have been previously associated with 2 other corneal dystrophies: fleck corneal dystrophy (in a single family) and autosomal-recessive congenital hereditary corneal endothelial dystrophy (CHED2) (in 3 families). [21] [22] [23] Each of these intronic changes was predicted to inactivate the splice acceptor site and therefore result in skipping of the adjacent exon, although none were actually demonstrated to result in a truncated protein product. [21] [22] [23] Although we screened the intron-exon boundaries of each of the 35 genes in the common PPCD1/CHED1 interval and did not identify any sequence variants involving the splice donor or acceptor sites, we acknowledge that we may have missed an intronic variant positioned further away from the intron-exon boundary.
The failure of our candidate gene screening strategy to identify a likely causative mutation provides the rationale for a more intensive approach to searching for the PPCD-related mutation. To identify a pathogenic deletion, genomic rearrangement, or intronic mutation in the common PPCD1 interval, we plan to perform large-scale resequencing of the entire 2.4 cM region between markers D20S182 and D20S139. Although quantitative real-time PCR is a useful technique to detect a deletion involving a portion or all of the coding region of a gene of interest, as the authors have used previously, 24 it would not be able to detect a pathogenic intronic variant. The recent development of large-scale resequencing strategies, by contrast, makes sequencing of FIGURE 2. European population haplotype frequencies of 3 associated SNPs genotyped in the CEPH HapMap trios. The rare T-T-T haplotype (rs6111803, rs1053834, rs1053839) that is associated with PPCD has a population frequency of 0.042 (4.2%).
FIGURE 3.
European population LD of the 3 associated SNPs genotyped in the CEPH HapMap trios. LD is given as the r 2 between SNPs. The SNPs rs1053834 and rs1053839 are in complete LD (r 2 = 1) in the CEPH HapMap trios. There is no LD between rs6111803 and either rs1053834 or rs1053839 (r 2 = 0.022 and 0.028, respectively). the entire 2.4 cM common PPCD1 interval possible and thus will permit identification of any variation in the nucleotide sequence in this interval, including deletions, insertions, substitutions, and genomic rearrangements. Given the demonstration of significant linkage of 4 SNPs with the disease allele in the common PPCD1 support interval, providing compelling evidence for the localization of the pathogenic mutation to this region, we believe resequencing the entire common PPCD1 support interval will lead to the identification of the genetic basis of PPCD1.
